DK1556375T3 - Flavonderivater som inhibitorer af cyklinafhængige kinaser - Google Patents

Flavonderivater som inhibitorer af cyklinafhængige kinaser

Info

Publication number
DK1556375T3
DK1556375T3 DK03753911T DK03753911T DK1556375T3 DK 1556375 T3 DK1556375 T3 DK 1556375T3 DK 03753911 T DK03753911 T DK 03753911T DK 03753911 T DK03753911 T DK 03753911T DK 1556375 T3 DK1556375 T3 DK 1556375T3
Authority
DK
Denmark
Prior art keywords
cyclin
inhibitors
dependent kinases
flavone derivatives
flavone
Prior art date
Application number
DK03753911T
Other languages
Danish (da)
English (en)
Inventor
Bansi Lal
Kalpana Sanjay Joshi
Malcolm Mascarenhas
Maggie Joyce A Nirmal C Rathos
Sanjeev Anant Kulkarni
Shrikant Gangadhar Kamble
Rajendrakumar Dinanath Joshi
Original Assignee
Nicholas Piramal India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd filed Critical Nicholas Piramal India Ltd
Application granted granted Critical
Publication of DK1556375T3 publication Critical patent/DK1556375T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK03753911T 2002-07-08 2003-07-07 Flavonderivater som inhibitorer af cyklinafhængige kinaser DK1556375T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN616MU2002 2002-07-08
PCT/IN2003/000234 WO2004004632A2 (en) 2002-07-08 2003-07-07 Flavone derivatives as inhibitors of cyclin-dependent kinases

Publications (1)

Publication Number Publication Date
DK1556375T3 true DK1556375T3 (da) 2008-11-03

Family

ID=30012269

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03753911T DK1556375T3 (da) 2002-07-08 2003-07-07 Flavonderivater som inhibitorer af cyklinafhængige kinaser

Country Status (20)

Country Link
EP (1) EP1556375B1 (ru)
JP (1) JP4860148B2 (ru)
KR (1) KR100991920B1 (ru)
CN (1) CN1668613B (ru)
AR (1) AR041184A1 (ru)
AT (1) ATE399162T1 (ru)
AU (1) AU2003272070B2 (ru)
BR (1) BR0312633A (ru)
CA (1) CA2492130C (ru)
DE (1) DE60321808D1 (ru)
DK (1) DK1556375T3 (ru)
ES (1) ES2309338T3 (ru)
IL (1) IL166153A (ru)
MX (1) MXPA05000388A (ru)
NZ (1) NZ537518A (ru)
PT (1) PT1556375E (ru)
RU (1) RU2334746C2 (ru)
TW (1) TWI331034B (ru)
WO (1) WO2004004632A2 (ru)
ZA (1) ZA200500138B (ru)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915301B2 (en) 2002-07-08 2011-03-29 Piramal Life Science Limited Inhibitors of cyclin dependent kinases and their use
BRPI0621777A2 (pt) * 2006-06-21 2013-03-12 Piramal Life Sciences Ltd derivados de flavona enantiomericamente puros para o tratamento de distérbios proliferativos e processos para sua preparaÇço
JP5006396B2 (ja) 2006-07-07 2012-08-22 ピラマル・ライフ・サイエンシーズ・リミテッド ピロリジン置換フラボンのエナンチオ選択的合成
BRPI0721626A2 (pt) * 2007-05-15 2013-01-22 Piramal Life Sciences Ltd combinaÇço farmacÊutica sinergÍstica para o tratamento de cÂncer
CN101333205A (zh) * 2008-07-10 2008-12-31 大连理工大学 周期素依赖蛋白激酶抑制剂黄芩素哌嗪衍生物及其制法
TWI461194B (zh) 2009-05-05 2014-11-21 Piramal Entpr Ltd 吡咯啶取代黃酮作為輻射致敏劑
WO2010129858A1 (en) * 2009-05-08 2010-11-11 Georgia State University Research Foundation Compounds and compositions comprising cdk inhibitors and methods for the treatment of cancer
US7928067B2 (en) 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
AU2010346973A1 (en) * 2010-02-26 2012-10-18 Piramal Enterprises Limited Pyrrolidine substituted flavones for the treatment of inflammatory disorders
CA2817362C (en) 2010-11-18 2018-10-23 Ischemix Llc Lipoyl compounds and their use for treating ischemic injury
EP2640380A1 (en) * 2010-11-19 2013-09-25 Piramal Enterprises Limited Pharmaceutical combination of paclitaxel and a cdk inhibitor
WO2012069972A1 (en) 2010-11-19 2012-05-31 Piramal Life Sciences Limited A pharmaceutical combination for the treatment of breast cancer
WO2012123889A1 (en) 2011-03-14 2012-09-20 Piramal Healthcare Limited A synergistic pharmaceutical combination for the treatment of pancreatic cancer
UY34013A (es) * 2011-04-13 2012-11-30 Astrazeneca Ab ?compuestos de cromenona con actividad anti-tumoral?.
TW201300105A (zh) * 2011-05-31 2013-01-01 Piramal Life Sciences Ltd 治療頭頸鱗狀細胞癌之相乘藥物組合物
EP2723449A2 (en) 2011-06-24 2014-04-30 Piramal Enterprises Limited Compounds for the treatment of cancers associated with human papillomavirus
WO2013105056A1 (en) 2012-01-13 2013-07-18 Piramal Enterprises Limited Pyrrolidine- substituted flavone derivatives for prevention or treatment of oral mucositis
WO2014049515A1 (en) * 2012-09-25 2014-04-03 Piramal Enterprises Limited Pyrrolidine substituted flavones for treatment of renal cystic diseases
EP3019166B1 (en) 2013-07-12 2019-05-08 Piramal Enterprises Limited A pharmaceutical combination for the treatment of melanoma
US10555931B2 (en) 2014-05-28 2020-02-11 Piramal Enterprises Limited Pharmaceutical combination for the treatment of cancer
US10308619B2 (en) * 2015-06-23 2019-06-04 Covestro Deutschland Ag Substituted triazines and a method for producing same
KR102275758B1 (ko) 2016-03-28 2021-07-12 프레시지 바이오싸이언시스, 인크. 암 치료를 위한 제약학적 조합물
BR112019005526A2 (pt) 2016-10-20 2019-06-18 Pfizer agentes antiproliferativos para tratamento de pah
US10744115B2 (en) 2017-04-25 2020-08-18 Ischemix Llc Compositions and methods for treating traumatic brain injury
CN107573270B (zh) * 2017-09-29 2019-11-29 河南师范大学 一种α-甲酰基吡咯烷类化合物的合成方法
CN112839714A (zh) 2018-10-19 2021-05-25 豪夫迈·罗氏有限公司 用于治疗和预防乙型肝炎病毒疾病的色烯-4-酮衍生物
CN110028475B (zh) * 2019-05-13 2022-07-01 中国药科大学 基于苯并吡喃结构的新型cdk9抑制剂、其制备方法及应用
KR20220122637A (ko) 2019-11-28 2022-09-02 바이엘 악티엔게젤샤프트 면역 활성화를 위한 dgk알파 억제제로서의 치환된 아미노퀴놀론
AR121719A1 (es) 2020-04-03 2022-06-29 Petra Pharma Corp Inhibidores alostéricos de cromenona del fosfoinosítido 3-quinasa (pi3k) para el tratamiento de enfermedades
IL307950A (en) 2021-05-03 2023-12-01 Petra Pharma Corp Allosteric chromanone inhibitors of PHOSPHOINOSITIDE 3-KINASE (PI3K) for the treatment of diseases
BR112023022890A2 (pt) 2021-05-27 2024-01-23 Petra Pharma Corp Inibidores de cromenona alostéricos de fosfoinositídio 3-cinase (pi3k), composições farmacêuticas que os compreendem e usos dos mesmos
CN113549044B (zh) * 2021-07-23 2024-01-23 中国药科大学 8-氮杂环取代色酮类衍生物及其制备方法与制药用途
TW202329930A (zh) 2021-09-30 2023-08-01 美商佩特拉製藥公司 用於治療疾病之磷酸肌醇3-激酶(pi3k)之異位色烯酮抑制劑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5733920A (en) * 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
CN1433410A (zh) * 2000-05-03 2003-07-30 株式会社Lg生命科学 具有3-羟基色烯-4-酮结构的cdk抑制剂

Also Published As

Publication number Publication date
CN1668613B (zh) 2012-07-04
IL166153A (en) 2009-11-18
EP1556375A2 (en) 2005-07-27
JP4860148B2 (ja) 2012-01-25
KR100991920B1 (ko) 2010-11-04
AU2003272070B2 (en) 2009-02-26
IL166153A0 (en) 2006-01-15
CN1668613A (zh) 2005-09-14
JP2006502109A (ja) 2006-01-19
AR041184A1 (es) 2005-05-04
AU2003272070A1 (en) 2004-01-23
ATE399162T1 (de) 2008-07-15
DE60321808D1 (de) 2008-08-07
TW200406202A (en) 2004-05-01
WO2004004632A2 (en) 2004-01-15
RU2334746C2 (ru) 2008-09-27
WO2004004632A8 (en) 2005-03-24
KR20050017110A (ko) 2005-02-21
WO2004004632A3 (en) 2004-09-16
BR0312633A (pt) 2005-07-19
ZA200500138B (en) 2006-02-22
PT1556375E (pt) 2008-10-03
NZ537518A (en) 2008-02-29
TWI331034B (en) 2010-10-01
CA2492130A1 (en) 2004-01-15
MXPA05000388A (es) 2005-09-30
CA2492130C (en) 2011-09-06
RU2005102939A (ru) 2005-09-10
ES2309338T3 (es) 2008-12-16
EP1556375B1 (en) 2008-06-25

Similar Documents

Publication Publication Date Title
DK1556375T3 (da) Flavonderivater som inhibitorer af cyklinafhængige kinaser
DK1463506T3 (da) Substituerede quinazolin-derivater som inhibitorer af aurora-kinaser
DK1562589T3 (da) Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser
DK1585749T3 (da) Diazepinoindol-derivater som kinaseinhibitorer
SE0701538L (sv) Azaspiroalkanderivat som hämmare av metalloproteaser
NO20045220L (no) Heterocykliske inhibitorer for kinaser
DK1664043T3 (da) Sammensætninger egnede som inhibitorer af proteinkinaser
DK1581515T3 (da) Triazolderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase-1
DK1532138T3 (da) Inhibitorer af tyrosinkinaser
DK1720882T3 (da) Pyrazolopyrimidin-derivater som cyclin-afhængige kinaseinhibitorer
DK1686999T3 (da) Pyrazolderivater som inhibitorer af receptortyrosinkinaser
DK1438306T3 (da) Derivater af UK-2A
NO20023828L (no) Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
NO20043726L (no) Heteroarylforbindelser anvendelige som inhibitorer av GSK-3
NO20050072L (no) Nye inhibitorer av kinaser
NO20043793L (no) Nikotinamidderivater anvendelige som PDE4 inhibitorer
NO20055421D0 (no) Kinolinderivater som fosfodiestrase-inhibitorer
DK1562902T3 (da) 2-pyridonderivater som inhibitorer af neutrofilelastase
DK2039685T3 (da) Heterobicycliske forbindelser som P38-inhibitorer
DK1658292T3 (da) Triazologyrimidinderivater som glycogensynthasekinase 3 - inhibitorer
DK1761505T3 (da) Pyrimidin-urinstof-derivater som kinaseinhibitorer
DK1633712T3 (da) Seks leddede amino-amid derivater som angiogenese inhibitorer
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO20050665L (no) Pyrrolidonderivater som MAOE inhibitoere
DK1786799T3 (da) Hidtil ukendte phenylaminopyrimidinderivater som inhibitorer af bcr-abl-kinase